In November 2018, at the House of Lords, Accord partnered with Generics bulletin to bring influential industry experts together at an intimate roundtable to talk about how pharma companies should drive consistent and
9th January 2018: Accord Healthcare is pleased to announce EC approval has been granted for its purchase of European Economic Area (EEA) rights to a basket of 13 products from TEVA.
Following a major acquisition of another leading generic pharmaceutical company, Accord Healthcare looks to continue to supply the generic medicine industry while mitigating the risks that come with acquisitions.
Accord Healthcare in the Spotlight of New Statesman magazine, the supplement dedicated to Healthcare
Accord Healthcare were honoured to be shortlisted in several categories at The Global Generics & Biosimilars Awards, taking place on Tuesday the 23rd of October.